Has doxycycline, in combination with anti-malarial drugs, a role to play in intermittent preventive treatment of Plasmodium falciparum malaria infection in pregnant women in Africa?
Abstract According to the World Health Organization (WHO), Plasmodium falciparum malaria during pregnancy is responsible for deleterious consequences for the mother and her child. The administration of intermittent preventive treatment (IPTp) with sulfadoxine–pyrimethamine (SP) at each antenatal car...
Main Authors: | Tiphaine Gaillard, Manon Boxberger, Marylin Madamet, Bruno Pradines |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | Malaria Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12936-018-2621-x |
Similar Items
-
Anti-malarial drugs: how effective are they against <it>Plasmodium falciparum </it>gametocytes?
by: Peatey Christopher L, et al.
Published: (2012-02-01) -
Are k13 and plasmepsin II genes, involved in Plasmodium falciparum resistance to artemisinin derivatives and piperaquine in Southeast Asia, reliable to monitor resistance surveillance in Africa?
by: Francis Foguim Tsombeng, et al.
Published: (2019-08-01) -
Low polymorphisms in pfact, pfugt and pfcarl genes in African Plasmodium falciparum isolates and absence of association with susceptibility to common anti-malarial drugs
by: Francis Tsombeng Foguim, et al.
Published: (2019-08-01) -
Prevalence of molecular markers of <it>Plasmodium falciparum</it> drug resistance in Dakar, Senegal
by: Wurtz Nathalie, et al.
Published: (2012-06-01) -
A conserved metabolic signature associated with response to fast-acting anti-malarial agents
by: Nelson V. Simwela, et al.
Published: (2023-12-01)